{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T08:48:18Z","timestamp":1649062098362},"reference-count":11,"publisher":"Informa UK Limited","issue":"14","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2021,12,6]]},"DOI":"10.1080\/10428194.2021.1986220","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T06:12:55Z","timestamp":1632982375000},"page":"3318-3319","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Does the conventional cytogenetic risk profile still matter for prediction of venetoclax based treatment outcomes in AML?"],"prefix":"10.1080","volume":"62","author":[{"given":"Jan Philipp","family":"Bewersdorf","sequence":"first","affiliation":[{"name":"Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.","family":"Stone","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Leukemia Division, Dana-Farber Cancer Institute, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin S.","family":"Tallman","sequence":"additional","affiliation":[{"name":"Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Stahl","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Leukemia Division, Dana-Farber Cancer Institute, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-733196"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0028"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2012971"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020004856"},{"key":"CIT0005","doi-asserted-by":"crossref","unstructured":"Venugopal S, Maiti A, DiNardo C, et\u00a0al. Prognostic impact of conventional cytogenetics in acute myeloid leukemia treated with venetoclax and decitabine. Leuk Lymphoma. 2021;1\u20135.","DOI":"10.1080\/10428194.2021.1973675"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30210-6"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003988"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1605949"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516192"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001904"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-138821"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2021.1986220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T12:51:33Z","timestamp":1639399893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2021.1986220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":11,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2021,12,6]]}},"alternative-id":["10.1080\/10428194.2021.1986220"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2021.1986220","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}